BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

273 related articles for article (PubMed ID: 28717813)

  • 1. Cut-off Points for Muscle Mass - Not Grip Strength or Gait Speed - Determine Variations in Sarcopenia Prevalence.
    Masanés F; Rojano I Luque X; Salvà A; Serra-Rexach JA; Artaza I; Formiga F; Cuesta F; López Soto A; Ruiz D; Cruz-Jentoft AJ
    J Nutr Health Aging; 2017; 21(7):825-829. PubMed ID: 28717813
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cut-off points to identify sarcopenia according to European Working Group on Sarcopenia in Older People (EWGSOP) definition.
    Bahat G; Tufan A; Tufan F; Kilic C; Akpinar TS; Kose M; Erten N; Karan MA; Cruz-Jentoft AJ
    Clin Nutr; 2016 Dec; 35(6):1557-1563. PubMed ID: 26922142
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Adherence to a standardized protocol for measuring grip strength and appropriate cut-off values in adults over 65 years with sarcopenia: a systematic review protocol.
    Fox B; Henwood T; Schaap L; Bruyère O; Reginster JY; Beaudart C; Buckinx F; Roberts H; Cooper C; Cherubini A; dellʼAquilla G; Maggio M; Volpato S
    JBI Database System Rev Implement Rep; 2015 Oct; 13(10):50-9. PubMed ID: 26571282
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prevalence of sarcopenia and its associated factors: the impact of muscle mass, gait speed, and handgrip strength reference values on reported frequencies.
    Moreira VG; Perez M; Lourenço RA
    Clinics (Sao Paulo); 2019 Apr; 74():e477. PubMed ID: 30994709
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Respiratory Muscle Strength as a Discriminator of Sarcopenia in Community-Dwelling Elderly: A Cross-Sectional Study.
    Ohara DG; Pegorari MS; Oliveira Dos Santos NL; de Fátima Ribeiro Silva C; Monteiro RL; Matos AP; Jamami M
    J Nutr Health Aging; 2018; 22(8):952-958. PubMed ID: 30272099
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Performance of the EWGSOP2 Cut-Points of Low Grip Strength for Identifying Sarcopenia and Frailty Phenotype: A Cross-Sectional Study in Older Inpatients.
    Stuck AK; Mäder NC; Bertschi D; Limacher A; Kressig RW
    Int J Environ Res Public Health; 2021 Mar; 18(7):. PubMed ID: 33800552
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Using two different algorithms to determine the prevalence of sarcopenia.
    Yoshida D; Suzuki T; Shimada H; Park H; Makizako H; Doi T; Anan Y; Tsutsumimoto K; Uemura K; Ito T; Lee S
    Geriatr Gerontol Int; 2014 Feb; 14 Suppl 1():46-51. PubMed ID: 24450560
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Prevalence of sarcopenia in Spanish nursing homes: Comparison of the results of the ELLI study with other populations].
    Salvà A; Serra-Rexach JA; Artaza I; Formiga F; Rojano I Luque X; Cuesta F; López-Soto A; Masanés F; Ruiz D; Cruz-Jentoft AJ
    Rev Esp Geriatr Gerontol; 2016; 51(5):260-4. PubMed ID: 27068239
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prevalence of sarcopenia in patients attending outpatient geriatric clinics: the ELLI study.
    Cuesta F; Formiga F; Lopez-Soto A; Masanes F; Ruiz D; Artaza I; Salvà A; Serra-Rexach JA; Rojano I Luque X; Cruz-Jentoft AJ
    Age Ageing; 2015 Sep; 44(5):807-9. PubMed ID: 26220989
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The Prevalence of Sarcopenia in Chinese Elderly Nursing Home Residents: A Comparison of 4 Diagnostic Criteria.
    Zeng Y; Hu X; Xie L; Han Z; Zuo Y; Yang M
    J Am Med Dir Assoc; 2018 Aug; 19(8):690-695. PubMed ID: 29891183
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Epidemiology of sarcopenia among community-dwelling older adults in Taiwan: a pooled analysis for a broader adoption of sarcopenia assessments.
    Wu IC; Lin CC; Hsiung CA; Wang CY; Wu CH; Chan DC; Li TC; Lin WY; Huang KC; Chen CY; Hsu CC;
    Geriatr Gerontol Int; 2014 Feb; 14 Suppl 1():52-60. PubMed ID: 24450561
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The feasibility of assessing frailty and sarcopenia in hospitalised older people: a comparison of commonly used tools.
    Ibrahim K; Howson FFA; Culliford DJ; Sayer AA; Roberts HC
    BMC Geriatr; 2019 Feb; 19(1):42. PubMed ID: 30770722
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The prevalence of sarcopenia in very old individuals according to the European consensus definition: insights from the BELFRAIL study.
    Legrand D; Vaes B; Matheï C; Swine C; Degryse JM
    Age Ageing; 2013 Nov; 42(6):727-34. PubMed ID: 24014657
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prevalence of sarcopenia and its components in community-dwelling outpatient older adults and their relation with functionality.
    Bahat G; Tufan A; Kilic C; Karan MA; Cruz-Jentoft AJ
    Aging Male; 2020 Dec; 23(5):424-430. PubMed ID: 30290756
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prevalence and Associated Factors of Sarcopenia in Singaporean Adults-The Yishun Study.
    Pang BWJ; Wee SL; Lau LK; Jabbar KA; Seah WT; Ng DHM; Ling Tan QL; Chen KK; Jagadish MU; Ng TP
    J Am Med Dir Assoc; 2021 Apr; 22(4):885.e1-885.e10. PubMed ID: 32693999
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Prevalence of sarcopenia in geriatric outpatients and nursing homes. The ELLI study].
    Osuna-Pozo CM; Serra-Rexach JA; Viña J; Gómez-Cabrera Mdel C; Salvá A; Ruiz D; Masanes F; Lopez-Soto A; Formiga F; Cuesta F; Cruz-Jentoft A
    Rev Esp Geriatr Gerontol; 2014; 49(2):72-6. PubMed ID: 23583189
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Basis for Sarcopenia Screening With the SARC-CalF in Nursing Homes.
    Urzi F; Šimunič B; Buzan E
    J Am Med Dir Assoc; 2017 Nov; 18(11):991.e5-991.e10. PubMed ID: 28866357
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Application of Cut-Points for Low Muscle Strength and Lean Mass in Mobility-Limited Older Adults.
    Grosicki GJ; Travison TG; Zhu H; Magaziner J; Binder EF; Pahor M; Correa-de-Araujo R; Cawthon PM; Bhasin S; Orwig D; Greenspan S; Manini T; Massaro J; Santanasto A; Patel S; Fielding RA
    J Am Geriatr Soc; 2020 Jul; 68(7):1445-1453. PubMed ID: 32633836
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prevalence of sarcopenia: the impact of different diagnostic cut-off limits.
    Beaudart C; Reginster JY; Slomian J; Buckinx F; Locquet M; Bruyère O
    J Musculoskelet Neuronal Interact; 2014 Dec; 14(4):425-31. PubMed ID: 25524968
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Physical function-derived cut-points for the diagnosis of sarcopenia and dynapenia from the Canadian longitudinal study on aging.
    Tessier AJ; Wing SS; Rahme E; Morais JA; Chevalier S
    J Cachexia Sarcopenia Muscle; 2019 Oct; 10(5):985-999. PubMed ID: 31307126
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.